Molecular Switches: Intellectual Property Landscape market Growth Analysis by 2035

Comments · 120 Views

The new market report titled ‘Molecular Switches: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents, describing the various types of Molecular Switches.

The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain.

 

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/molecular-switches-patents-landscape.html

 

Main Chapters in the Molecular Switches Intellectual Property Landscape report

  • Overall Intellectual Property Landscape

An analytical perspective of the various patents and affiliated IP documents that have been published related to Molecular Switches. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent RD trends within this domain.

 

  • Popular / Relevant Prior Art Search Expressions

An examination of IP literature, shortlisting key words and phrases used to describe Molecular Switches. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.

 

  • Patent Valuation Analysis

A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.

 

  • Patentability and Freedom to Operate

A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.

 

A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to Molecular Switches, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.

 

  • Pockets of Innovation and White Spaces

An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.

 

  • Claim Analysis

One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim.

 

Key Companies Profiled

  • 13therapeutics
  • 3M
  • A2 Biotherapeutics
  • Anacor Pharmaceuticals
  • Brown University
  • Cellectis
  • European Molecular Biology Laboratory
  • Fujifilm Cellular Dynamics
  • Genzyme
  • Immetacyte

 

To understand the complete structure of the report, get its PDF sample copy

https://www.rootsanalysis.com/reports/molecular-switches-patents-landscape/request-sample.html

 

 

You may also be interested in the following titles:

Cell Therapy Manufacturing Market

Global TCR Therapy Market

 

You may also like to learn what our experts are sharing in Roots educational series:

Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

 

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

                       

Contact:

Ben Johnson

+1 (415) 800 3415
[email protected]

Comments